China plans to restrict exports of a critical metal. But the market isn’t that worried

China plans to restrict exports of a critical metal. But the market isn’t that worried


Key Points
  • China will start limiting exports of critical metal tungsten this weekend, just as alternatives to Chinese suppliers of the metal are reopening.
  • Tungsten is an extremely hard metal used in weapons and semiconductors.
  • The U.S. has not commercially mined tungsten since 2015, according to official records. But this year, one of the world’s largest mines for the metal is moving close to resuming production in South Korea.



Source

JPMorgan Chase reins in lending to private credit firms after marking down software loans
Finance

JPMorgan Chase reins in lending to private credit firms after marking down software loans

Key Points JPMorgan is marking down collateral held by private credit firms and reducing their borrowing capacity — a preemptive move driven by market valuations, not actual loan losses. The markdowns target software company loans, where AI advances have sparked fears of disintermediation, triggering a private credit downcycle and abnormally high redemptions at firms like […]

Read More
Stocks making the biggest moves premarket: Oracle, AeroVironment, Nike and more
Finance

Stocks making the biggest moves premarket: Oracle, AeroVironment, Nike and more

Check out the companies making headlines before the bell. Oracle — Oracle shares jumped more than 9% after the cloud infrastructure company gave strong fiscal third quarter results and lifted its revenue guidance for fiscal 2027. Management lifted its fiscal 2027 revenue outlook up $1 billion to $90 billion. Analysts polled by LSEG sought $86.6 […]

Read More
Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more
Finance

Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more

Check out some of the companies making the biggest moves midday: Hims & Hers Health — Shares of the telehealth company jumped 3%. Bank of America upgraded the stock to neutral from underperform after Novo Nordisk dropped its patent infringement case against Hims, and the companies agreed that Hims would sell Novo’s Ozempic and Wegovy […]

Read More